|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02656 160 HEALTH
Nominal 
100.000 -3.900 (-3.754%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | -- | -- | 620,682 | 628,606 | 525,646 |
| Cost of Sales | -- | -- | (460,495) | (491,279) | (407,359) |
| Gross Profit | -- | -- | 160,187 | 137,327 | 118,287 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (8,284) | (7,333) | (1,022) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | (106,956) | (110,676) | (118,957) | |
| Taxation | -- | -- | (1,290) | (547) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 5,024 | (1,108) | |
| Non-controlling Interests | -- | -- | 559 | (2,617) | 8,760 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (72,986) | -32.224% | (107,687) | (108,816) | (111,305) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 2,330 | 11,156 | 39,773 |
| Depreciation & Amortisation | -- | -- | 10,826 | 11,631 | 11,245 |
| Directors' Emoluments | -- | -- | 24,392 | 18,600 | 2,775 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -24.000 | -- | -- | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- |
| NBV per share ($) | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 01/04/2026 17:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -72,986 |
| %Change | -32.224% |
| EPS / (LPS) | RMB -0.240 |
| NBV Per Share (¥) | RMB -- |